Tenecteplase in Acute Ischemic Stroke
Pharmacy to Dose: The Critical Care Podcast
00:00
The Advantages and Disadvantages of Tinek to Place
Tinek to Place was manipulated in the lab with the idea that this is going to be a better option. It's 80 times more resistant to PAI as opposed to AltaPlase, which I thought was an interesting point, an interesting fact. That means that you can just give it as a bolus and sort of a Bolus and an infusion. And also, basically, Plasmid and Activator and inhibitor, so it doesn't get inactivated that fast. But yes, if I had to highlight two things that matter the most, one is that they made it so that it's more fibrant specific.
Transcript
Play full episode
